Pharma Journalist, Author at Pharma Journalist - Page 38 of 901

Johnson & Johnson Reports Promising OrigAMI-4 Trial Results

Boehringer Ingelheim, NIPER Raebareli Sign Research MoU

Catalent, S.Biomedics Partner on Parkinson’s Cell Therapy

Johnson & Johnson Invests $1 Billion in Pennsylvania

Unnatural Products, Novartis Partner on Macrocyclic Therapies

Scribe, Lilly Advance CRISPR Therapies With Milestone

Teijin, Aska Partner on Gynecology Drug Discovery

The Toxicology Meeting That’s Different – Made for Biotech and Pharma Leaders

Immunic Raises $400M to Advance MS Drug Plans

FDA Rejects Bitopertin Accelerated Approval for Rare Disorder